# MTBO - L12 - Pharmacokinetics 1

```pdf
'url': './MTBO - L12 - Slides.pdf'
"page": 2
```
Noroclox is an intramammary 

```pdf
'url': './MTBO - L12 - Slides.pdf'
"page": 3
```

```pdf
'url': './MTBO - L12 - Slides.pdf'
"page": 4
```

```pdf
'url': './MTBO - L12 - Slides.pdf'
"page": 5
```

```pdf
'url': './MTBO - L12 - Slides.pdf'
"page": 6
```

```pdf
'url': './MTBO - L12 - Slides.pdf'
"page": 7
```

```pdf
'url': './MTBO - L12 - Slides.pdf'
"page": 8
```

```pdf
'url': './MTBO - L12 - Slides.pdf'
"page": 9
```

```pdf
'url': './MTBO - L12 - Slides.pdf'
"page": 10
```

```pdf
'url': './MTBO - L12 - Slides.pdf'
"page": 11
```

```pdf
'url': './MTBO - L12 - Slides.pdf'
"page": 12
```
Topical on skin
Parenteral is underskin
Monoclonal antibodies cannot be done orally

```pdf
'url': './MTBO - L12 - Slides.pdf'
"page": 13
```

```pdf
'url': './MTBO - L12 - Slides.pdf'
"page": 14
```

```pdf
'url': './MTBO - L12 - Slides.pdf'
"page": 15
```

```pdf
'url': './MTBO - L12 - Slides.pdf'
"page": 16
```

```pdf
'url': './MTBO - L12 - Slides.pdf'
"page": 17
```

```pdf
'url': './MTBO - L12 - Slides.pdf'
"page": 18
```

```pdf
'url': './MTBO - L12 - Slides.pdf'
"page": 19
```

```pdf
'url': './MTBO - L12 - Slides.pdf'
"page": 20
```

```pdf
'url': './MTBO - L12 - Slides.pdf'
"page": 21
```

```pdf
'url': './MTBO - L12 - Slides.pdf'
"page": 22
```


```pdf
'url': './MTBO - L12 - Slides.pdf'
"page": 23
```

```pdf
'url': './MTBO - L12 - Slides.pdf'
"page": 24
```

```pdf
'url': './MTBO - L12 - Slides.pdf'
"page": 25
```

```pdf
'url': './MTBO - L12 - Slides.pdf'
"page": 26
```
Water of hydration is how much water is in the drug

```pdf
'url': './MTBO - L12 - Slides.pdf'
"page": 27
```

```pdf
'url': './MTBO - L12 - Slides.pdf'
"page": 28
```

```pdf
'url': './MTBO - L12 - Slides.pdf'
"page": 29
```

```pdf
'url': './MTBO - L12 - Slides.pdf'
"page": 30
```

```pdf
'url': './MTBO - L12 - Slides.pdf'
"page": 31
```

```pdf
'url': './MTBO - L12 - Slides.pdf'
"page": 32
```
IV is 100% bioavailable

```pdf
'url': './MTBO - L12 - Slides.pdf'
"page": 33
```
Larger less frequent increases in period and amplitude

```pdf
'url': './MTBO - L12 - Slides.pdf'
"page": 34
```

```pdf
'url': './MTBO - L12 - Slides.pdf'
"page": 35
```

```pdf
'url': './MTBO - L12 - Slides.pdf'
"page": 36
```

```pdf
'url': './MTBO - L12 - Slides.pdf'
"page": 37
```


```pdf
'url': './MTBO - L12 - Slides.pdf'
"page": 38
```
Elsewhere = 2nd compartment, all compartments are in equilibrium
Physiological components impact the equilibrium constant
Distribution is a dynamic process
Lower plasma proteins can impact disease and drug interactions

```pdf
'url': './MTBO - L12 - Slides.pdf'
"page": 39
```

```pdf
'url': './MTBO - L12 - Slides.pdf'
"page": 40
```

```pdf
'url': './MTBO - L12 - Slides.pdf'
"page": 41
```
